Voice of the Voiceless: How we co-produced materials to help reduce stigma for people receiving opioid substitution therapy in pharmacies

 

 

By Dr Vicky Carlisle, Research Fellow, Bristol Medical School, University of Bristol

Voice of the Voiceless is a collaboration between people who receive opioid substitution therapy (OST) for opioid dependence, University of Bristol academics (Dr Vicky Carlisle, Dr Adam Holland, Dr Jenny Scott), Bristol City Council (Ashley Ward), Bristol Drugs Project (Lydia Plant, Lianna Telfer), Developing Health & Independence (Nick Booth), and Harm Reduction Mothers2Mothers (Anna Millington). In 2024 we worked together with a graphic designer to co-produce a booklet that aims to: reduce stigma for people who receive opioid substitution treatment; empower them in their interactions in pharmacies; and foster mutual compassion and respect between pharmacy staff and people who receive OST.

Why stigma and why pharmacies?

OST (with methadone or buprenorphine) is prescribed for opioid dependence. Broadly, the aim is to provide individuals with stability  and relief from withdrawal symptoms, and to reduce reliance … Read more

My experience as an NIHR School for Primary Care Research intern: a pharmacy student’s perspective

Loreta Valatka

 

 

by Loreta Valatka, Third Year Pharmacy Student, University of Bath

 

My internship experience

The Carry Naloxone Somerset project, led by Dr Jenny Scott, was the main focus of my 2023 research summer internship at the University of Bristol’s Centre for Academic Primary Care (CAPC). The aim of the project is to encourage people in Somerset who may experience or witness an overdose to carry naloxone – a first aid medicine that can be supplied without prescription to prevent an opioid overdose from being fatal.

Before the launch of the campaign, I analysed survey data to write a report about the possession and carriage of naloxone, as well as overdose experiences amongst Somerset Drug and Alcohol Service (SDAS) users. Post launch, I was responsible for follow-ups with the 23 pharmacies that had signed up so far. This was to ensure all participating members of the pharmacy teams … Read more

Prescribing and the environment

 

 

by Dr Rupert Payne, Consultant Senior Lecturer in Primary Health Care, Centre for Academic Primary Care, University of Bristol

Boots pharmacies made the mainstream news headlines in May this year when it became apparent that some prescriptions which were being prepared using an automated centralised system were being distributed using plastic bags. Lloyds pharmacies have a similar process in place.

The argument is that the centralised assembly process is more efficient and safer than the old-fashioned local approach which used paper bags. The bags can be recycled but, as many of us know, that isn’t necessarily straightforward. Given the backlash against plastic that has been seen recently, and particularly given the fact that pharmacies have always been well known for using paper bags, it is unsurprising that this change has been received negatively by consumers.

But the impact of prescribing on the environment is not just … Read more

Repeat prescriptions are expensive and time consuming – it’s time for an NHS rethink

 

Dr Rupert Payne
Centre for Academic Primary Care
@DrRupertPayne

 

 

Dr Céline Miani
University of Bielefeld
@celine_miani

 

Over a billion NHS prescription medicines are issued by pharmacists in England every year – at a cost of over £9 billion. Many of these are prescribed by GPs to manage long-term health conditions, such as diabetes or cardiovascular disease.

The current “repeat prescription” system allows patients to request a further supply of medicines without the inconvenience of another doctor’s appointment.

The UK Department of Health advises that the frequency of repeat prescriptions should “balance patient convenience with clinical appropriateness, cost-effectiveness and patient safety”.

However, it does not recommend a specific time period. As a result, local health service commissioners have developed their own guidance, with many encouraging GPs to issue short-term supplies of repeat medications, typically 28 days in length. This is supported by the UK’s Pharmaceutical Services Read more